UK researchers are studying whether gamified technology can improve engagement, enjoyment and performance for children during clinical walking assessments.
Clinical Trials Day highlights UK’s research teams advancing patient care through clinical trials, expanding access to new treatments and driving innovation across Kentucky.
Researchers at UK HealthCare are now enrolling patients in the phase 3 AZALEA trial to evaluate the safety and efficacy of an investigational medication in pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN).
UK researchers are co-leading a new $7.2 million NIH-funded study testing overdose prevention strategies for women transitioning from jail back into rural Kentucky.
UK Markey Cancer Center is the first site in the country to open a clinical trial for ZG006, an experimental drug that works by connecting disease-fighting T cells to cancer cells.
Researchers at UK HealthCare are now enrolling patients in the phase 3 AZALEA trial to evaluate the safety and efficacy of an investigational medication in pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN).
Cancer patient Debra Kantosky was offered the opportunity to participate in a clinical trial to determine if allowing patients to choose their own tobacco cessation treatment and level of coaching helps them quit.
The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.
